QbDVision
QbDVision is a private Austin-based SaaS company that provides a purpose-built Digital CMC platform — digital product, process, method, and tech-transfer definitions — for biopharmaceutical companies and CDMOs managing regulated drug development and manufacturing lifecycles.
- Company typePrivate
- Founded2015
- HeadquartersAustin, United States
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What QbDVision does
QbDVision, Inc. (formerly CherryCircle Software, Inc.) is a private Austin, Texas-based SaaS company founded in 2015 by Yash Sabharwal and Ryan Shillington that builds a Digital CMC (Chemistry, Manufacturing, and Controls) platform for biopharmaceutical organizations and contract development and manufacturing organizations (CDMOs). The cloud-native platform is purpose-built for the structured, knowledge-intensive demands of pharmaceutical product lifecycle management and unifies digital product, process, method, and tech-transfer definitions into a governed, ICH-aligned (Q8–Q12, Q14) knowledge system with built-in compliance to 21 CFR Part 11, EU Annex 11, ISO 27001:2022, and SOC 2. It runs on AWS in a GAMP5 Category 3 serverless architecture and exposes structured data and AI capabilities for LLM-assisted ingestion, contextual search, and automated report authoring.
The company sells through a hybrid GTM: enterprise field sales for Professional and Professional-XR deployments at large biopharma firms and CDMOs; inside sales for mid-market accounts; and self-serve SaaS via the Essentials tier at $49 per user per month, alongside Professional at $229 and Professional-XR at $259 per user per month. Pricing is publicly disclosed, and the platform is offered as subscription SaaS with add-on professional services for implementation and validation. QbDVision reports 95% customer retention and lists Bayer, Sanofi/TranslateBio, ViralGen, AskBio, Glycomine, Cue Biopharma, BLES, and Alcresta Therapeutics among its users, supported by a headcount of 11–50 and approximately $28 million in total funding across a February 2022 Series A ($15M led by Northpond Ventures) and a May 2025 Series A extension ($13M).
QbDVision firmographics
Firmographics- Name
- QbDVision
- Legal name
- QbDVision, Inc.
- Website
- https://qbdvision.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- QbDVision is a private Austin-based SaaS company that provides a purpose-built Digital CMC platform — digital product, process, method, and tech-transfer definitions — for biopharmaceutical companies and CDMOs managing regulated drug development and manufacturing lifecycles.
- Ownership category
- akta.pro rank
QbDVision industry classification
Industry- Product category
- Pharmaceutical Manufacturing Software (Digital CMC / Pharma PLM)
- NAICS
- Computer Systems Design Services (541512), Computer Systems Design and Related Services (54151)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD)
- akta.pro secondary industry
- Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)
Keywords
Where QbDVision is headquartered
LocationHeadquarters
- HQ city
- Austin
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
QbDVision business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- SaaS Subscription (Per Seat): Subscription-based SaaS model with per-user/per-seat pricing. Three tiers: Essentials ($49/user/month), Professional ($229/user/month), and Professional-XR ($259/user/month). Annual and monthly billing options available.
- Professional Services: Implementation, training, and validation services likely offered as add-on professional services for enterprise deployments.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Per seat | Monthly | Essentials - Early-Stage/Preclinical: Basic electronic quality and product lifecycle management at $49/user/month |
| Per seat | Monthly | Professional - Process Development: Full platform access for process development activities at $229/user/month |
| Per seat | Monthly | Professional-XR - Clinical Manufacturing & Process Validation: Validated version for GMP-level activities at $259/user/month |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels7 records
QbDVision product offering
Product offeringCore offering
QbDVision sells a cloud-based Digital CMC (Chemistry, Manufacturing, and Controls) software platform purpose-built for biopharmaceutical organizations and CDMOs. The platform unifies product, process, method, and transfer knowledge into a single structured digital system that supports the full product lifecycle from early-stage R&D through commercial manufacturing and validation. It is offered as a per-seat SaaS subscription across three tiers and is used to digitize CMC data, accelerate tech transfers, and provide AI-ready structured data infrastructure for pharma development.
Product overview
QbDVision offers a unified Digital CMC Platform as its core product, built as a structured platform purpose-built for pharma and biotech. The platform operates on a modular architecture with distinct capability areas: Digital Product Definition for product attribute intelligence, Digital Process Definition for manufacturing process knowledge, Digital Method Definition for traceable analytical methods, and Digital Tech Transfer for streamlining transfers. Supporting modules include Knowledge Management (Know Where), Process Development (Know How), Process Intelligence (Know Why), and Structured Data and AI. The platform is available in three tiers: Essentials ($49/user/month) for early-stage/preclinical use, Professional ($229/user/month) for full process development access, and Professional-XR ($259/user/month) for GMP-compliant validated environments. All offerings share the same foundational platform infrastructure and provide end-to-end product lifecycle management from R&D through commercial manufacturing.
Differentiator
Problem solved
Functional benefit
Products and services
- Digital CMC Platform An end-to-end Digital CMC lifecycle platform providing product lifecycle management capabilities from R&D to commercial manufacturing. It is built as a unified framework connecting product, process, method, and transfer knowledge, and includes capabilities for Digital Product Definition, Digital Process Definition, Digital Method Definition, Digital Tech Transfer, Knowledge Management, Process Development, Process Intelligence, and Structured Data and AI. The platform is sold on a per-seat SaaS subscription across three tiers (Essentials, Professional, Professional-XR) to biopharmaceutical organizations and CDMOs globally.
Quantifiable outcome
- 80% reduction in tech transfer times
- +5 more outcomes
Companies that use QbDVision
Customer profileNamed customers8 records
Segments3 records
Ideal customer profiles3 records
QbDVision technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
AI capability6 records
Feature7 records
QbDVision partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Amazon Web Services (AWS)coreCloud infrastructure provider for QbDVision's SaaS platform. AWS provides the foundation for the serverless architecture with best-in-class security features. AWS is an Approved Supplier for AI services with data never leaving AWS/Azure to reduce attack surface.
- Project Artemis (Industry Collaboration)coreCollaboration with industry leaders on Project Artemis initiative to build the Digital CMC ecosystem. QbDVision works with partners to solve some of pharma and biotech's biggest digital challenges through industry-wide cooperation and standard-setting.
Scale indicators9 records
Recent moves7 records
Expansion highlights6 records
QbDVision competitors and assessment
Company assessmentBroad incumbents
- BIOVIA (Dassault Systèmes): Broad scientific informatics portfolio covering formulation, process development, and quality. Competes with QbDVision's Digital Process Definition but as part of a much wider enterprise PLM and scientific software suite.
- Sparta Systems (Honeywell): TrackWise QMS for life sciences, owned by Honeywell, targeting similar biopharma quality and compliance use cases as QbDVision but as part of a broader industrial software portfolio.
- Veeva Systems: Largest life sciences cloud platform, with Vault Quality, Vault RIM, and Vault Development Suites that overlap with QbDVision's QMS and CMC capabilities. Veeva serves most of the top 25 biopharma but as a broad portfolio, not a CMC-specialist.
Direct peers
- MasterControl: Direct competitor in life sciences QMS, quality management, and document control software. Targets the same biopharma and CDMO buyer with comparable GxP compliance and validation offerings.
- Dotmatics: Scientific R&D informatics platform for life sciences that handles structured experimental data and process development workflows, directly comparable to QbDVision's Digital CMC and process intelligence capabilities.
- ValGenesis: Validation lifecycle management platform for life sciences targeting similar biopharma customers with comparable regulatory compliance, validation, and electronic records capabilities.
- Benchling: Biotech R&D platform with structured data capture for biology, molecules, and process development. Competes with QbDVision's structured product/process/method definition and is increasingly overlapping in bioprocess and CMC-adjacent use cases.
- IDBS (Dassault Systèmes): Biopharma R&D data management platform with structured data capture and process intelligence features. Now part of Dassault, IDBS directly overlaps with QbDVision's Digital CMC platform for biopharma customers.
- Kneat Solutions: GxP validation lifecycle management software for life sciences, directly comparable to QbDVision's Professional-XR validation package and CDQ/qualification capabilities for regulated environments.
Emerging players
- LabVantage Solutions: LIMS platform with biopharma focus that integrates with QbDVision and overlaps in analytical method and process data management for life sciences labs and CDMOs.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
QbDVision social profiles
Digital presenceQbDVision compliance and trust
Trust signalCompliance5 records
QbDVision financial estimates
Financial estimateRevenue estimate
Valuation estimate
QbDVision leadership team
Management profileNumber of profiles
Profiles8 records
QbDVision funding detail
Funding detailFunding overview
Funding rounds4 records
Investors7 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
QbDVision M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about QbDVision
What does QbDVision do?
QbDVision sells a cloud-based Digital CMC (Chemistry, Manufacturing, and Controls) software platform purpose-built for biopharmaceutical organizations and CDMOs. The platform unifies product, process, method, and transfer knowledge into a single structured digital system that supports the full product lifecycle from early-stage R&D through commercial manufacturing and validation. It is offered as a per-seat SaaS subscription across three tiers and is used to digitize CMC data, accelerate tech transfers, and provide AI-ready structured data infrastructure for pharma development.
Is QbDVision a public or private company?
QbDVision is a private company. It is classified as venture growth investor backed and is currently operating.
When was QbDVision founded?
QbDVision was founded in 2015. It employs 51 to 100 people.
Where is QbDVision based?
QbDVision is headquartered in Austin, United States, in the North America region.
How does QbDVision make money?
Two revenue lines are on record. SaaS Subscription (Per Seat) is the primary driver. The others are professional Services.
Who are QbDVision's main competitors?
Broad incumbents on record are BIOVIA (Dassault Systèmes), Sparta Systems (Honeywell) and Veeva Systems. Direct peers are MasterControl, Dotmatics, ValGenesis, Benchling, IDBS (Dassault Systèmes) and Kneat Solutions. LabVantage Solutions is listed as an emerging player.
Does QbDVision have an API?
No public API is recorded for QbDVision.
What industry is QbDVision in?
QbDVision's product category is Pharmaceutical Manufacturing Software (Digital CMC / Pharma PLM). Its primary akta.pro industry code is HLAIALAD, CMC & Pharmaceutical Development (Formulation/Process/Analytical Development), with a secondary code of HLAGAHAM, Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC). Its NAICS code is 541512 and its SIC code is 7372.